Results from Abbott's PROSPECT Study Provide New Insight
- Details
- Category: Abbott
![Abbott Abbott](http://www.worldpharmanews.com/images/stories/logo/abbott.gif)
Herceptin provides impressive survival benefit for patients with high levels of HER2
- Details
- Category: Roche
![Roche Roche](http://www.worldpharmanews.com/images/stories/logo/roche.gif)
Results of ADAGIO study with Azilect® in Parkinson's disease published
- Details
- Category: Lundbeck
![H. Lundbeck A/S H. Lundbeck A/S](http://www.worldpharmanews.com/images/stories/logo/lundbeck.gif)
Nexavar® Demonstrates 74 Percent Improvement in Progression-Free Survival
- Details
- Category: Bayer
![The Bayer Group The Bayer Group](http://www.worldpharmanews.com/images/stories/logo/bayer.gif)
Analysis of BRAIN study shows that patients may have a stabilisation or improvement
- Details
- Category: Roche
![Roche Roche](http://www.worldpharmanews.com/images/stories/logo/roche.gif)
Denosumab Demonstrates Superiority Over Zometa(R)
- Details
- Category: Amgen
![Amgen Amgen](http://www.worldpharmanews.com/images/stories/logo/amgen.gif)
Pfizer and Wyeth to Divest Certain Animal Health Assets to Boehringer Ingelheim
- Details
- Category: Pfizer
![Pfizer Inc Pfizer Inc](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
More Pharma News ...
- Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO-ESMO Congress 2009
- Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO-ESMO Congress
- U.S. FDA Licenses Sanofi Pasteur's Pandemic Influenza Vaccine
- Novartis investigational bronchodilator QAB149 compared to tiotropium
- Appeals Court Affirms Patent Infringement Rulings Against Roche's peg-EPO Product
- Lilly Unveils Blueprint for Speeding Innovative Medicines to Patients
- Two new studies report increased survival rates in Tamiflu-treated patients